EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Efficacy and Effectiveness of High Molecular Weight Non‐Cross‐Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy

Alberto Leguina-Ruzzi iD, Alejandro Navarro iD, Marjorie Zambrano

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70484 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Alberto Leguina-Ruzzi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universidad Andrés Bello, Santiago, Región Metropolitana, Chile. Hauptthemen laut MEDLINE: Rosacea, Hyaluronic Acid, Mesotherapy, Succinic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rosacea is a highly prevalent dermatosis affecting 5% of the world's population. Its impact is not only physical but also psychological, as over 60% of patients with rosacea also suffer from depression, anxiety, and other psychological comorbidities. Currently, topical treatments yield low or unsatisfactory success rates, and rosacea complications such as disfigurement, burning sensation, and pain can greatly affect patients' well‐being. Intra‐dermotherapy with high molecular weight non‐cross‐linked hyaluronic acid plus succinic acid has shown anti‐inflammatory, regenerative, and vascular modulatory effects.

Objectives

To evaluate the efficacy and effectiveness of high molecular weight non‐cross‐linked hyaluronic acid (HMWNCHA) plus succinic acid (SA) mesotherapy in rosacea patients who are not responding to topical treatments. To determine the degree of improvement in general parameters such as erythema, telangiectasia, and skin laxity and hydration. To compare the cost of this treatment with that of laser therapy, a widely used modality.

Methods

We performed a non‐randomized, controlled interventional study, and we evaluated the results after three sessions (once monthly) as the primary endpoint of this mesotherapy, using a product containing 1.1% of high molecular weight non‐cross‐linked hyaluronic acid plus 1.6% succinic acid (full face, 2 mL per session, administered using the papule technique) in a group of 20 male and female patients, aged 40–45 years, Fitzpatrick skin types I–III, without comorbidities. All patients were already undergoing topical treatment with Ivermectin 1%, Metronidazole 0.75%, and photoprotection, but without good results or clear improvement, quantified as a reduction in the Investigator's Global Assessment (IGA) severity score of at least 1 point. Erythema, hydration, and facial telangiectasia were evaluated at every session for proper quantification. Our study group was compared with a control group that only continued their topical treatment, and the study lasted 4 months, with a prospective follow‐up at 6 months.

Results

Our results showed a reduction of 80% in the baseline erythema, an improvement of 30% in skin hydration, and a reduction of 20% in facial telangiectasia after three sessions, compared with patients who used only topical treatment. In addition, the costs were significantly lower than those of three sessions of laser therapy in a private healthcare setting.

Conclusion

We demonstrated that using this acid combination in mesotherapy is an efficient, safe, and cost‐effective adjunct therapy for patients already using a particular topical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaHyaluronic AcidMesotherapySuccinic AcidHumansFemaleAdultMiddle AgedTreatment OutcomeMaleCombined Modality TherapyMolecular Weight

Stichwörter der Autor:innen

adjunct therapydermatosishigh molecular weight hyaluronic acidmesotherapyrosaceaskin qualitysuccinic acid

Substanzen

Hyaluronic AcidSuccinic Acid

Autor:innen und Institutionen

  • Faculty of Medicine, Universidad Andrés Bello, Santiago, Región Metropolitana, Chile.
  • TotalSkin Clinic, Santiago, Chile.
  • Faculty of Medical Sciences, Universidad de Guayaquil, Escuela de Medicina, Guayaquil, Ecuador.

ORCID-Profile: Alberto Leguina-Ruzzi, Alejandro Navarro

Zitieren

APA

Leguina-Ruzzi, A., Navarro, A., & Zambrano, M. (2025). Efficacy and Effectiveness of High Molecular Weight Non‐Cross‐Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70484

Vancouver

Leguina-Ruzzi A, Navarro A, Zambrano M. Efficacy and Effectiveness of High Molecular Weight Non‐Cross‐Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70484

BibTeX
@article{LeguinaRuzzi2025,
  author = {Leguina-Ruzzi, Alberto and Navarro, Alejandro and Zambrano, Marjorie},
  title = {Efficacy and Effectiveness of High Molecular Weight Non‐Cross‐Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70484}
}
Kostenlos starten →